(19)
(11) EP 1 100 962 A1

(12)

(43) Date of publication:
23.05.2001 Bulletin 2001/21

(21) Application number: 99934895.6

(22) Date of filing: 20.07.1999
(51) International Patent Classification (IPC)7C12Q 1/68, C07K 14/705, A61K 38/10, G06F 17/00
(86) International application number:
PCT/GB9902/340
(87) International publication number:
WO 0006/768 (10.02.2000 Gazette 2000/06)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 25.07.1998 GB 9816192
22.08.1998 GB 9818280

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • SMITH, John Craig
    Macclesfield,Cheshire SK10 4TG (GB)
  • ANAND, Rakesh
    Macclesfield,Cheshire SK10 4TG (GB)
  • MORTEN, John Edward Norris
    Macclesfield,Cheshire SK10 4TG (GB)

(74) Representative: Gainey, Laurence David Scott (GB) et al
AstraZeneca PLCGlobal Intellectual PropertyMeresideAlderley Park
Macclesfield, Cheshire SK10 4TG
Macclesfield, Cheshire SK10 4TG (GB)

   


(54) GENETIC POLYMORPHISMS IN THE HUMAN NEUROKININ 1 RECEPTOR GENE AND THEIR USES IN DIAGNOSIS AND TREATMENT OF DISEASES